Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of LeonaBio (NASDAQ:LONA) through any online brokerage.
Other companies in LeonaBio’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
LeonaBio has a consensus price target of $17.33.
The stock price for LeonaBio (NASDAQ: LONA) is $4.8599 last updated October 2, 2026 at 7:28 PM EDT.
There are no upcoming dividends for LeonaBio.
LeonaBio does not have any upcoming earnings scheduled.
There is no upcoming split for LeonaBio.
LeonaBio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.